Skip to content
10-Q

Quarterly Report

RESHAPE LIFESCIENCES INC.

0001558370-20-006627

← back to feed
Filed
May 14, 2020 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2020 · May 12, 2020 5.48M sh
Long Term Debt Q1 2020 · Mar 31, 2020 $2.76M
Long Term Debt Q1 2020 · Dec 31, 2019 $2.73M
Cash And Equivalents Q1 2020 · Mar 31, 2020 $2.12M
Cash And Equivalents Q1 2020 · Dec 31, 2019 $2.94M
Current Liabilities Q1 2020 · Mar 31, 2020 $10.76M
Current Liabilities Q1 2020 · Dec 31, 2019 $10.39M
Total Liabilities Q1 2020 · Mar 31, 2020 $15.99M
Total Liabilities Q1 2020 · Dec 31, 2019 $15.55M
Current Assets Q1 2020 · Mar 31, 2020 $8.51M
Current Assets Q1 2020 · Dec 31, 2019 $10.11M
Total Assets Q1 2020 · Mar 31, 2020 $37.56M
Total Assets Q1 2020 · Dec 31, 2019 $39.66M
Operating Cash Flow Q1 2020 · Mar 31, 2019 −$5.7M
Stockholders Equity Q1 2020 · Mar 31, 2019 $28.57M
Stockholders Equity Q1 2020 · Dec 31, 2018 $31.66M
Sga Expense restated Q1 2020 · Mar 31, 2019 $1.12M
Rd Expense Q1 2020 · Mar 31, 2019 $1.06M
Net Income Q1 2020 · Mar 31, 2019 −$4.48M
Operating Income Q1 2020 · Mar 31, 2019 −$4.25M
Gross Profit Q1 2020 · Mar 31, 2019 $2.23M
Revenue Q1 2020 · Mar 31, 2019 $3.07M
Short Term Debt Q1 2020 · Mar 29, 2019 $1.5M